Category Archives: Oral Medications

Inhaled Insulin to Treat Diabetes Earns FDA Committee Recommendation

The inhaled insulin Afrezza has been recommended for approval by a Food and Drug Administration (FDA) advisory committee. The drug, an inhaled powder, completed phase III testing in August of 2013. If approved, it will be the first ultra rapid-acting mealtime insulin therapy available in the United States. The advisory committee recommended that the drug … Continue reading Inhaled Insulin to Treat Diabetes Earns FDA Committee Recommendation

Type 2: Oramed Sends Oral Insulin Test Request to FDA

Israel-based Oramed announced that it has sent an application to the Food and Drug Administration for permission to enter Phase 2 trials of its oral insulin product. The company has been working on developing a means of delivering insulin orally, which would allow people with diabetes to avoid having to inject themselves with the hormone. … Continue reading Type 2: Oramed Sends Oral Insulin Test Request to FDA

ACP Guidelines Say Metformin Is the Best Starter Drug for Type 2s

The latest clinical guidelines for treating type 2 diabetes from the American College of Physicians (ACP) indicate that when diet, exercise, and weight loss fail to control blood sugar levels in early type 2 patients, physicians should prescribe metformin as the first drug therapy. The ACP recommends that metformin be prescribed initially as a stand-alone … Continue reading ACP Guidelines Say Metformin Is the Best Starter Drug for Type 2s

FDA Gives Long-Awaited Nod to Amylin’s Bydureon

After several years of delays and setbacks, Amylin Pharmaceuticals has received FDA approval to begin US marketing of BydureonTM. The first once-a-week type 2 therapy to be offered in the US market, Bydureon is expected to be available by February. Amylin says that its wholesale price will be about $4,200 a year. The drug is … Continue reading FDA Gives Long-Awaited Nod to Amylin’s Bydureon